Vasopressin and Observational Analgesia in Healthy Volunteers
Official title: The Influence of Vasopressin on Observational Learning of Placebo Analgesia
Run by University of Maryland, Baltimore · NCT03446456 · Data updated 2026-11-12
We are testing whether intranasal vasopressin changes how people’s pain is shaped by watching others experience pain while in an MRI scan.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | University of Maryland, Baltimore Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting · results posted |
| Started | September 17, 2018 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT03446456 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18–55 who are English speakers without significant medical or psychiatric conditions.
✕Probably not a fit
Individuals with the listed exclusion criteria or those not experiencing pain may not derive any analgesic benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study explores how the hormone vasopressin might alter brain responses to pain when people watch others receive analgesia. It uses an interventional design with random assignment to vasopressin or saline, and a blinded setup for participants and researchers. The procedure includes an observational phase followed by a pain-testing phase in an fMRI environment to measure neural activity related to pain and social processing. The primary aim is to see if vasopressin enhances brain regions involved in social cognition during observational analgesia. The trial uses healthy adults aged 18–55 and excludes individuals with major health, psychiatric, or sensory risk factors.
Why it matters
Potential benefit: If successful, the approach could improve understanding of how vasopressin modulates socially influenced pain experiences and inform future analgesic strategies.
How similar studies have gone: This area combines genetics, neurochemistry, and social learning; prior work suggests social influence can modulate pain, but the specific role of vasopressin in observational analgesia is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ( 18-55 years old) * English speaker (written and spoken) Exclusion Criteria: * Cardiovascular, neurological diseases, pulmonary abnormalities, kidney disease, liver disease, degenerative neuromuscular disease, history of cancer within past 3 years * Any history of chronic pain disorder or currently in pain * Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, mania, autism) and /or psychiatric condition leading to treatment and/or hospitalization within the last 3 years. * Family (first degree) history of mania, schizophrenia, or other psychoses * Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months * Pregnancy or breast feeding * Color-blindness * Impaired, uncorrected hearing * History of angioedema * High blood pressure (above 140 mmHg) or symptomatic low blood pressure * History of fainting * Left handed * Allergies or sensitivities to creams, lotions or food coloring * Any non-organic implant or any non-removable metal device (e.g. pacemaker, cochlear implants, stents, surgical clips, non-removable piercings) * Any prior eye injury or the potential of a foreign body in the eye (e.g. worked in metal fields)Persisting functional impairment due to a head trauma * Fear of closed spaces * Any other contraindications for MRI (e.g. large tattoos on head and neck) * Previously participated in a "Pain Perception in the Brain" Study * Failed drug test (testing for opiates, cocaine, methamphetamines, amphetamines and THC)
Where it's running
-
Luana Colloca
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Luana Colloca, MD/PHD/MS — University of Maryland Baltimore School of Nursing
- Study coordinator: Research Coordinator
- Email: nrscollocalab@umaryland.edu
- Phone: 410-706-5975
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictors of severe pain within 24 hours after cesarean delivery with spinal anesthesia
This study will look at which pre-, intra-, and post-operative factors are linked to severe pain in the first 24 hours after an elective cesarean done with spinal anesthesia.
-
Transverse vs Longitudinal Serratus Anterior Plane Block for Breast Surgery
This trial tests whether a longitudinal ultrasound view for serratus anterior plane block provides better pain relief after breast surgery than the standard transverse view.
-
Combined PECS II and PIP blocks vs TPVB for post-mastectomy pain relief
This trial tests whether a combination of PECS II and superficial PIP blocks can provide better or similar pain relief after mastectomy compared with the standard thoracic paravertebral block.
-
Ketamine or Dexmedetomidine as an Additive to Scalp Block for Brain Tumor Surgery
This trial tests whether adding ketamine or dexmedetomidine to bupivacaine for scalp blocks improves pain control after supratentorial brain tumor removal.
-
Rhythmic Skin Tapping and Internal Vibration for Pediatric Venipuncture Pain and Fear
This study tests whether light fingertip tapping above the needle site or a humming sound can reduce pain and fear in children aged 6-12 during blood draws.
-
Brief audio-guided mindfulness for pain in orthopedic waiting rooms
This trial tests whether listening to short mindfulness audio clips can help reduce pain for adults waiting for orthopedic care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.